Trajectories of a Composite Lipid, Glucose, and Refined Obesity Index Predict Cardiovascular Disease
Cardiovascular Therapeutics · 2026-01 · 2026 (1)
DOI: 10.1155/cdr/1092234 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Therapeutics, online erschienen am 04.11.2026. Verfasst von Linying Xia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Blood Glucose, Obesity, Lipids. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Insulin resistance and central adiposity are key drivers of cardiovascular disease (CVD). Although the CHG index and obesity‐related indicators can separately predict metabolic risks, this study explored the predictive value of their composite indices and longitudinal trajectories for incident CVD.
Methods
Based on 4164 middle‐aged and elderly participants from a national prospective cohort, we analyzed baseline levels, cumulative exposures and K‐means‐defined longitudinal trajectories of CHG‐related composite indices. Cox regression, ROC analysis, and weighted quantile sum regression were adopted to explore CVD associations and predictive efficiency.
Results
During an 8‐year median follow‐up, 22.14% of participants developed CVD. Elevated baseline values, increased cumulative exposure, and unfavorable trajectories of composite indices were linked to higher CVD risk. Per 1‐SD rise in baseline CHG‐WC and CHG‐CVAI corresponded to 19% and 17% higher CVD risk, respectively. Their addition produced statistically significant improvements in predictive performance and risk stratifying capacity of the Framingham Risk Score, as further supported by NRI and IDI analyses.
Conclusion
Longitudinal trajectories and cumulative exposures of CHG‐obesity composite indices serve as reliable independent predictors of CVD. Dynamic monitoring of these indicators facilitates early CVD risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Shaanxi International Travel Healthcare Center (Xi'an Customs Port Outpatient Department), Xi'an, Shaanxi, China.
- Department of Epidemiology, Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University, Xi'an, Shaanxi, China, fmmu.edu…
ORCID-Profile: Linying Xia, Tengfei Ji, Yuan Wang, Danni Li, Yuyu Sun, Wenwen Wang, Jie Deng
Zitieren
APA
Xia, L., Ji, T., Wang, Y., Li, D., Sun, Y., Wang, W., & Deng, J. (2026). Trajectories of a Composite Lipid, Glucose, and Refined Obesity Index Predict Cardiovascular Disease. Cardiovascular Therapeutics, 2026(1). https://doi.org/10.1155/cdr/1092234
Vancouver
Xia L, Ji T, Wang Y, Li D, Sun Y, Wang W, et al. Trajectories of a Composite Lipid, Glucose, and Refined Obesity Index Predict Cardiovascular Disease. Cardiovascular Therapeutics. 2026;2026(1). doi:10.1155/cdr/1092234
BibTeX
@article{Xia2026,
author = {Xia, Linying and Ji, Tengfei and Wang, Yuan and Li, Danni and Sun, Yuyu and Wang, Wenwen and Deng, Jie},
title = {Trajectories of a Composite Lipid, Glucose, and Refined Obesity Index Predict Cardiovascular Disease},
journal = {Cardiovascular Therapeutics},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/cdr/1092234}
}
EUVIMED